Special Series Part Two, Drug Interactions: Cannabis and Analgesics, Sympathomimetics, Liver Enzyme Inhibitors
Dr. Jose Lança is an M.D., Ph.D., and Assistant Professor of Pharmacology in the Faculty of Dentistry, and in the Department of Pharmacology and Toxicology in the Faculty of Medicine at the University of Toronto. In this interview, PART TWO, we’re talking with Dr. Lança about drug interactions (and implications) that can occur in patients regularly consuming cannabis and/or taking certain prescription medications (part two). In part three, Dr. Lança delivers important insights on treating patients within the current opioid crisis and provides evidence-based, alternative treatments for pain management. The implications for dental management when a patient is consuming cannabis and CNS depressants concurrently?
Special Series Part One, Impairment and Intoxication: Cannabis and Dental Management Read/download the transcript of the conversation (PDF)Full conversation (7.07″)Do dentists have to modify the dose of local anesthetics given to patients who are consuming cannabis regularly?
Read/download the transcript of the conversation (PDF)Full conversation (7.33″)Dental management and implications for patients taking sympathomimetics and consuming cannabis
Read/download the transcript of the conversation (PDF)Full conversation (7.31″)Dental Management for patients taking liver enzyme inhibiting drugs and consuming cannabis
Read/download the transcript of the conversation (PDF)Full conversation (6.59″)We always want to hear your thoughts and questions. Leave a comment about this post in the box below or send us your feedback by email or call us at 1-855-716-2747. Until next time! CDA Oasis Team |
Dr. Lanca, you say that Cannibis is a peripheral vasodilator but is also a vasoconstrictor in the cardiac and cerebral tissues. How can a drug be both a vasodilator and a vasoconstrictor? how does that work or happen?